|Videos|February 17, 2022
What Pharmacists Should Understand About the Trajectory of the Omicron Variant
Sachin Nagrani, MD, the medical director of Heal, discusses what pharmacists should know about the Omicron variant and other variants popping up globally.
Advertisement
Pharmacy Times interviewed Sachin Nagrani, MD, the medical director of Heal, on Pfizer’s research assessing an Omicron-specific vaccine for adults aged 18 to 55 years.
During the interview, Nagrani discussed what pharmacists should understand about the trajectory of the Omicron variant and whether there are other variants popping up in the world that Americans should be aware of.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Study Finds Persistent Gaps in Diagnoses for Depression and Chronic Conditions After COVID-19
2
Roundup: Every Most Favored Nation Agreement With the Trump Administration
3
Dato-DXd Granted Priority Review as First-Line Therapy for Metastatic Triple-Negative Breast Cancer
4
From CAR T to Gene Therapy, Pharmacists Prepare for What’s Next at the 2026 Tandem Meeting
5